Posts Tagged Moderate Impairment

[ARTICLE] Comparisons between end-effector and exoskeleton rehabilitation robots regarding upper extremity function among chronic stroke patients with moderate-to-severe upper limb impairment – Full Text

Abstract

End-effector (EE) and exoskeleton (Exo) robots have not been directly compared previously. The present study aimed to directly compare EE and Exo robots in chronic stroke patients with moderate-to-severe upper limb impairment. This single-blinded, randomised controlled trial included 38 patients with stroke who were admitted to the rehabilitation hospital. The patients were equally divided into EE and Exo groups. Baseline characteristics, including sex, age, stroke type, brain lesion side (left/right), stroke duration, Fugl–Meyer Assessment (FMA)–Upper Extremity score, and Wolf Motor Function Test (WMFT) score, were assessed. Additionally, impairment level (FMA, motor status score), activity (WMFT), and participation (stroke impact scale [SIS]) were evaluated. There were no significant differences in baseline characteristics between the groups. After the intervention, improvements were significantly better in the EE group with regard to activity and participation (WMFT–Functional ability rating scale, WMFT–Time, and SIS–Participation). There was no intervention-related adverse event. The EE robot intervention is better than the Exo robot intervention with regard to activity and participation among chronic stroke patients with moderate-to-severe upper limb impairment. Further research is needed to confirm this novel finding.

Introduction

Upper extremity dysfunction is a common complication after stroke, and it has been reported to affect approximately 85% of stroke survivors in the early stage1 and 50% in the chronic stage2. Impaired upper extremity function limits performance of activities of daily living (ADLs) and decreases social participation3. Novel therapeutic techniques have been introduced to promote upper extremity function, and one such technique is robotic rehabilitation.

Rehabilitation robots are capable of reducing the burden on therapists by substituting human intervention and providing ideal therapies that fulfil the following main principles of stroke rehabilitation: repetition, high intensity, and task specificity4. Thus, robotic intervention has been highlighted as a promising therapy. A recent multicentre randomised controlled trial showed better improvements in FMA scores with robot-assisted training on comparing robot-assisted training with usual care, but showed no significant difference in scores on comparing robot-assisted training with enhanced upper limb therapy. These findings indicate that robot-assisted training can reduce the burden for therapists but is not a definite superior option5. Many systematic reviews and meta-analyses on rehabilitation robots have been published in the last two decades. In 2012, Norouzi-Gheidari et al. summarised 10 trials that compared robotic therapy with dose-matched conventional therapy and reported no significant differences in Fugl–Meyer Assessment (FMA) of the upper extremity and Functional Independence Measure scores between the therapies6. However, with an increase in the number of randomised controlled trials, a recent review involving 38 trials reported a significant difference in the FMA–Upper Extremity score between robotic therapy and conventional therapy, with a better score for robotic therapy7.

Many rehabilitation robots for the upper extremity have been released and are available for clinical use. These robots have shown positive clinical results. Thus, healthcare professionals and patients have multiple choices among many kinds of robots; however, there is limited evidence to guide their choices. Physicians tend to prescribe ‘robot intervention’ rather than specify a particular robot, unlike medication prescription, when selecting robotic rehabilitation. So far, different rehabilitation robots have been considered broadly as rehabilitation robots per se, despite some differences in effectiveness.

Rehabilitation robots are generally categorised into end-effector (EE) and exoskeleton (Exo) types according to their mechanical structures8. EE robots are connected to patients at one distal point, and their joints do not match with human joints. Force generated at the distal interface changes the positions of other joints simultaneously, making isolated movement of a single joint difficult8,9. Exo robots resemble human limbs as they are connected to patients at multiple points and their joint axes match with human joint axes. Training of specific muscles by controlling joint movements at calculated torques is possible8,9. Recent systematic reviews have performed indirect comparisons by subgroup analysis and have demonstrated contradictory results for EE and Exo robots. Veerbeek et al. reported significant favourable results with regard to FMA–Upper Extremity for EE robots but not for Exo robots7. On the other hand, Bertani et al. reported significant favourable results with regard to arm function for Exo robots but not for EE robots; however, the risk of bias should be considered owing to the smaller sample size of Exo robots when compared with that of EE robots10. Although these indirect comparisons are helpful, they are limited by the heterogeneity in clinical studies, including design, population, outcomes, and intervention protocols.

Many new robotic devices have been developed; however, there are no guidelines or standard requirements with regard to the most appropriate robot subtype, extent of degrees of freedom, and approach (functionality based or impairment based) for favourable outcomes. To our knowledge, no head-to-head clinical trial comparing different types of rehabilitation robots has been performed. Such a comparison may help in the decision making of healthcare professionals with regard to rehabilitation robots and may ultimately offer more optimal rehabilitation for patients. In particular, there is a great need for a direct comparison study to clarify effects according to the types of robots, as robots are expensive.

Therefore, we performed a randomised controlled trial to directly compare EE and Exo robots in a selected population of chronic stroke patients with moderate-to-severe upper limb impairment. The InMotion2 (Interactive Motion Technologies, Watertown, MA, USA) and Armeo Power (Hocoma, Volketswil, Switzerland) robots were selected as representative EE and Exo robots, respectively, among commercially available robots for their proven efficacy and safety, as well as accessibility around hospitals11,12,13,14.

Methods

Study design

This single-blinded, randomised controlled trial was conducted at a single rehabilitation hospital. Participants were randomly allocated to an EE group and Exo group (1:1 ratio) by using concealed envelopes with a card representing the group assignment. Occupational therapists who carried out assessments were blinded to group allocation. The study was approved by the Ethics Committee of the National Rehabilitation Center, Korea and was carried out in accordance with the approved guidelines. Written informed consent was provided by all participants. The study was registered at ClinicalTrials.gov (NCT03104881).

Participants

For enrolment, the study considered 92 patients with stroke who were admitted to the rehabilitation hospital between March 2015 and August 2016. The inclusion criteria were as follows: (1) unilateral hemiplegic upper extremity dysfunction secondary to a unilateral ischaemic or haemorrhagic brain lesion; (2) stroke duration > 3 months; (3) FMA–Upper Extremity score of 8–30 for the affected upper extremity; and (4) ability to follow simple instructions. The exclusion criteria were as follows: (1) age < 20 years or > 80 years; (2) previous ischaemic or haemorrhagic stroke; (3) shoulder or elbow spasticity with a modified Ashworth scale (MAS) score ≥ 2; (4) severe upper extremity pain that could interfere with rehabilitation therapy; (5) neurological disorders other than stroke that can cause motor deficits, such as Parkinson’s disease, spinal cord injury, traumatic brain lesion, brain tumour, and peripheral neuropathy; and (4) uncontrolled severe medical conditions. Of the 92 patients, 53 did not meet the inclusion criteria or declined to participate. Thus, 39 patients were finally enrolled.

Intervention

All participants received robot-assisted therapy with InMotion2 (EE group) or Armeo Power (Exo group) (30 minutes of active therapy 5 days a week for 4 weeks [total 20 sessions]) along with conventional occupational therapy (30 minutes of therapy [total 20 sessions]). Both robot-assisted therapies were managed by the same experienced research physical therapist. The therapy period was quantified by considering the active intervention time and not the time for preparations, such as attaching the robot to the patient and aligning the axis of the robot to that of the patient. Conventional occupational therapy involved range of motion exercises, strengthening exercises for the affected upper extremity, and basic ADL training. Overall, the same dosing parameters, including frequency and duration, were applied in the EE and Exo groups.

EE group

The EE robot InMotion2 was used in the EE group. In the seated position, each participant held the handle attached to an arm support and performed goal-directed reaching movements in the gravity-compensated horizontal plane with two degrees of freedom, including the shoulder and elbow joints. From the starting point in the centre, the participant was instructed to move the handle toward eight targets positioned 45 degrees apart in circular arrangements, and the position of the handle was marked on the screen for real-time visual feedback (Fig. 1A). Reaching movements were supported through an assist-as-needed control system when targets could not be reached independently.

Figure 1

Two types of rehabilitation robots used for the robot-assisted therapy (A) InMotion2 for the EE group and (B) Armeo Power for the Exo group. EE, end-effector; Exo, exoskeleton.

[…]

via Comparisons between end-effector and exoskeleton rehabilitation robots regarding upper extremity function among chronic stroke patients with moderate-to-severe upper limb impairment | Scientific Reports

, , , , , , , , , ,

Leave a comment

[ARTICLE] Relationship Between Motor Capacity of the Contralesional and Ipsilesional Hand Depends on the Side of Stroke in Chronic Stroke Survivors With Mild-to-Moderate Impairment – Full Text

There is growing evidence that after a stroke, sensorimotor deficits in the ipsilesional hand are related to the degree of impairment in the contralesional upper extremity. Here, we asked if the relationship between the motor capacities of the two hands differs based on the side of stroke. Forty-two pre-morbidly right-handed chronic stroke survivors (left hemisphere damage, LHD = 21) with mild-to-moderate paresis performed distal items of the Wolf Motor Function Test (dWMFT). We found that compared to RHD, the relationship between contralesional arm impairment (Upper Extremity Fugl-Meyer, UEFM) and ipsilesional hand motor capacity was stronger (R2LHD=RLHD2= 0.42; R2RHDRRHD2 < 0.01; z = 2.12; p = 0.03) and the slope was steeper (t = −2.03; p = 0.04) in LHD. Similarly, the relationship between contralesional dWMFT and ipsilesional hand motor capacity was stronger (R2LHD=RLHD2= 0.65; R2RHDRRHD2 = 0.09; z = 2.45; p = 0.01) and the slope was steeper (t = 2.03; p = 0.04) in LHD compared to RHD. Multiple regression analysis confirmed the presence of an interaction between contralesional UEFM and side of stroke (β3 = 0.66 ± 0.30; p = 0.024) and between contralesional dWMFT and side of stroke (β3 = −0.51 ± 0.34; p = 0.05). Our findings suggest that the relationship between contra- and ipsi-lesional motor capacity depends on the side of stroke in chronic stroke survivors with mild-to-moderate impairment. When contralesional impairment is more severe, the ipsilesional hand is proportionally slower in those with LHD compared to those with RHD.

Introduction

It is now well-known that unilateral stroke not only results in weakness of the opposite half of the body, i.e., contralateral to the lesion or contralesional limb, but also significant motor deficits in the same half of the body, i.e., ipsilateral to the lesion or ipsilesional limb (14). Previous work suggests that deficits in the ipsilesional arm and hand varies with the severity of contralesional deficits, especially in the sub-acute and chronic phase after stroke (58). More interestingly, the unilateral motor deficits observed for contralesional and ipsilesional limbs seem to be hemisphere-specific and thus depend on side of stroke lesion (915). For predominantly right-handed cohorts, contralesional deficits appear to be more severe in those with right hemisphere damage (RHD), in whom the contralesional limb is non-dominant. For example, using clinical motor assessments of grip strength and hand dexterity, Harris and Eng (11) showed that contralesional motor impairments were less severe in chronic stroke survivors who suffered damage in the dominant (i.e., left) hemisphere (LHD) compared to those who suffered damage in the non-dominant (right) hemisphere (1115).

In contrast, considering ipsilesional motor deficits, the evidence is mixed concerning hemisphere-specific effects. For instance, some studies reported that individuals with LHD exhibited more severe ipsilesional arm and hand deficits compared to those with RHD (41517) while others have reported no difference in ipsilesional hand motor capacity between LHD and RHD (2). In acute stroke survivors, Nowak et al. demonstrated that deficits in grip force of the ipsilesional hand were significantly associated with clinical measures of function of the contralesional hand only in LHD (12). Contrary to this, de Paiva Silva et al. (14) found that compared to controls and LHD, the ipsilesional hand in chronic stroke survivors was significantly slower and less smooth in RHD especially when contralesional impairment was relatively more severe (UEFM < 34).

Taken together, there is converging evidence regarding the relationship between motor deficits of the contralesional and ipsilesional upper extremity, such that ipsilesional deficits are worse when contralesional impairment is greater (Figure 1A); however, it is uncertain whether the relationship between the two limbs depends on which hemisphere is damaged. In particular, motor deficits of the two limbs are most prominent for tasks that require dexterous motor control (e.g., grip force, tapping, tracking). For predominantly right-handed cohorts (as is the case in most studies), contralesional deficits appear to be more severe in those with RHD, in whom the contralesional limb is non-dominant; whereas ipsilesional deficits are more severe in those with LHD. An exception to this observation for those with RHD seems to be in the case when contralesional impairment is most severe (i.e., UEFM < 34) (14). Thus, one might predict that as contralesional impairment worsens, individuals with LHD would have proportionally worse ipsilesional deficits, but individuals with RHD (especially if say UEFM > 34) would not; see Figures 1B,C for two alternative hypotheses. To our knowledge, this prediction has not before been explicitly tested.

Figure 1. Hypothesized effects represented in schematic figure. (A) The null hypothesis, wherein the relationship between contralesional (CL) impairment and ipsilesional (IL) motor capacity is not modified by the side of stroke lesion, i.e., β1 ≠ 0 but β3 = 0. (B) Alternative hypothesis 1, wherein ipsilesional deficits are related to contralesional impairment but only in LHD (blue) and not in RHD (red). (C) Alternate hypothesis 2, wherein ipsilesional deficits are related to contralesional impairment but only in LHD and in RHD with severe impairment (represented in the shaded dark-gray area). For both alternate hypotheses, β1 and β3 ≠ 0.

[…]

via Frontiers | Relationship Between Motor Capacity of the Contralesional and Ipsilesional Hand Depends on the Side of Stroke in Chronic Stroke Survivors With Mild-to-Moderate Impairment | Neurology

, , , , , , , ,

Leave a comment

[Abstract] Functional Brain Stimulation in a Chronic Stroke Survivor With Moderate Impairment  

Abstract

OBJECTIVE. To determine the impact of transcranial direct current stimulation (tDCS) combined with repetitive, task-specific training (RTP) on upper-extremity (UE) impairment in a chronic stroke survivor with moderate impairment.

METHOD. The participant was a 54-yr-old woman with chronic, moderate UE hemiparesis after a single stroke that had occurred 10 yr before study enrollment. She participated in 45-min RTP sessions 3 days/wk for 8 wk. tDCS was administered concurrent to the first 20 min of each RTP session.

RESULTS. Immediately after intervention, the participant demonstrated marked score increases on the UE section of the Fugl–Meyer Scale and the Motor Activity Log (on both the Amount of Use and the Quality of Movement subscales).

CONCLUSION. These data support the use of tDCS combined with RTP to decrease impairment and increase UE use in chronic stroke patients with moderate impairment. This finding is crucial, given the paucity of efficacious treatment approaches in this impairment level.

Related Articles
Related Topics

Source: Functional Brain Stimulation in a Chronic Stroke Survivor With Moderate Impairment | American Journal of Occupational Therapy

, , , , , , , , , ,

Leave a comment

%d bloggers like this: